Search clinical trials for: Growth hormone releasing factor/Growth hormone releasing hormone

Total 62608 results

Novartis Pharmaceuticals

Recruiting

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

Breast Cancer

France, Germany, Spain, Portugal
Hoffmann-La Roche
GOG Foundation; European Network of Gynaecological Oncological Trial Groups...

Active, not recruiting

A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors (BOUQUET)

Ovarian Cancer

United States, Korea, Republic of, France, Germany, Spain, Italy, Canada, Russian Federation, United Kingdom, Turkey, Australia, Czechia, Switzerland
University of California, San Diego

Completed

Progestin-Only Pill Use and Breastfeeding Study

Contraception | Breastfeeding

United States
Pfizer

Active, not recruiting

A Study of PF-06873600 in People With Cancer

HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer

United States, Japan, Canada, Russian Federation, Bulgaria, Ukraine
Belgian Study Group for Pediatric Endocrinology

Active, not recruiting

A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height (ZomaTrip)

Idiopathic Short Stature

Belgium
Massachusetts General Hospital

Active, not recruiting

Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk

Obesity | Fatty Liver | Liver Fat | Obesity, Abdominal | Non-Alcoholic Fatty Liver Disease

United States
Columbia University

Terminated

Adult Growth Hormone Deficiency and Cardiovascular Risk

Growth Hormone Deficiency

United States
Theratechnologies

Completed

TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy

HIV Infections | Lipodystrophy

Canada, France, United States, United Kingdom, Spain, Belgium
Massachusetts General Hospital
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Tesamorelin Effects on Liver Fat and Histology in HIV

Nonalcoholic Steatohepatitis (NASH) | Human Immunodeficiency Virus (HIV) | Nonalcoholic Fatty Liver Disease (NAFLD)

United States
The University of Texas Medical Branch, Galveston

Completed

The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment

Mild Cognitive Impairment

United States
University of Pennsylvania

Completed

The Effect of GHRH Therapy on Myocardial Structure and Function in Congestive Heart Failure (GHRH)

Congestive Heart Failure

United States
University of Pennsylvania
National Institute on Aging (NIA)

Terminated

Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly

Aging | Hormone Deficiency

United States
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese

Growth Hormone Deficiency | Abdominal Obesity

United States
Massachusetts General Hospital

Completed

Effects of Growth Hormone Releasing Hormone in HIV

HIV | HIV Lipodystrophy

United States
Dauntless Pharmaceuticals

Completed

Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers

Healthy Volunteer Study

United States
Johns Hopkins University
Massachusetts General Hospital

Terminated

Six Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly (PP2)

Elderly

United States
Cairo University

Unknown

Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response

Subfertility

Egypt
University of Washington
National Institute of Mental Health (NIMH)

Completed

Growth Hormone Releasing Hormone (GHRH) Treatment for Age-Related Sleep Disturbances

Sleep Disorders
Stefania La Grutta, MD

Completed

Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD) (GHD)

Growth Hormone Deficiency
Merck KGaA, Darmstadt, Germany

Completed

Comparative Validation of the Growth Hormone Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone Deficiency

Growth Hormone Deficiency

France
Massachusetts General Hospital

Withdrawn

Abdominal Obesity, Cardiovascular Inflammation, and Effects of Growth Hormone Releasing Hormone Analogue

Abdominal Obesity

United States
Massachusetts General Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Effects of Short-term Growth Hormone in HIV-infected Patients

HIV Lipodystrophy

United States
University of Washington
National Institute on Aging (NIA)

Completed

SMART: Somatotrophics, Memory, and Aging Research Trial

Aging | Mild Cognitive Impairment

United States
Theratechnologies

Completed

Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients

HIV

Canada
Theratechnologies

Completed

TH9507 in Patients With HIV-Associated Lipodystrophy

HIV Infections | Lipodystrophy

United States, Canada
Versartis Inc.

Completed

VRS-317 in Adult Subjects With Growth Hormone Deficiency

Growth Hormone Deficiency

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Withdrawn

Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer

Prostate Cancer
Massachusetts General Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Effect of Short Term Growth Hormone Releasing Hormone in Healthy Men

Healthy Volunteers

United States
Rabin Medical Center
Pfizer

Completed

Growth and Metabolic Response to GH and GnRHa Treatment Versus GH Alone in Boys Born SGA.

SGA and Growth

Israel
Eunice Kennedy Shriver National Institute of Child...

Completed

Study of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature

Dwarfism | Growth Disorder

United States
National Center for Research Resources (NCRR)
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Study of Gonadotropin-Releasing Hormone Pulse Frequency in Sexual Maturation and in the Menstrual Cycle

Precocious Puberty | Hypogonadism

United States
National Center for Research Resources (NCRR)
University of Michigan

Completed

Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly

Acromegaly
MedSIR
Stemline Therapeutics, Inc.

Not yet recruiting

Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i. (ADELA)

Advanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | ESR1 Gene Mutation
Mayo Clinic

Not yet recruiting

Stereotactic Body Radiation Therapy Plus Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy for Treatment of Metastatic, Recurrent Hormone-Sensitive Prostate Cancer, DIVINE Trial (DIVINE)

Recurrent Prostate Cancer | Castration-resistant Prostate Cancer | Stage IVB Prostate Cancer AJCC v8 | Recurrent Castration-Sensitive Prostate Carcinoma

United States
Novartis Pharmaceuticals

Not yet recruiting

NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.

Metastatic Neuroendocrine Prostate Cancer
Mayo Clinic

Recruiting

Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment Prostate Cancer

Prostate Adenocarcinoma | Oligometastatic Prostate Carcinoma

United States
National Taiwan University Hospital
Debiopharm International SA; Ministry of Health and Welfare

Not yet recruiting

Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients (ESCALATE)

Triple Negative Breast Cancer | Premenopausal Breast Cancer
University of Washington
Breast Cancer Research Foundation

Not yet recruiting

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast Carcinoma | Locally Advanced Unresectable HER2-Negative Breast Carcinoma | Locally Advanced Unresectable Hormone Receptor-Positive...

United States
Debiopharm International SA

Recruiting

A Study to Assess the Efficacy, Safety and Pharmacokinetics of Debio 4326 in Pediatric Participants Receiving Gonadotropin-Releasing Hormone Agonist Therapy for Central Precocious Puberty (LIBELULA)

Central Precocious Puberty

United States
University Health Network, Toronto

Not yet recruiting

Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium (WE-FiERCE)

Endometrial Cancer | Atypical Hyperplasia
Sidney Kimmel Comprehensive Cancer Center at Johns...
United States Department of Defense; Prostate Cancer Foundation; Panbela Therapeutics

Recruiting

Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer

United States
Northwest Women's and Children's Hospital, Xi'an...

Not yet recruiting

Effectiveness of Generic Versus Reference Cetrorelix Acetate for Ovarian Stimulation Using a Gonadotropin-releasing Hormone（GnRH）Antagonist Protocol in Women Undergoing IVF

Infertility

China
Stephanie B. Seminara, MD

Recruiting

Dampening the Reproductive Axis With Continuous Kisspeptin

Polycystic Ovary Syndrome | PCOS | Reproductive Disorder

United States
Washington University School of Medicine
National Cancer Institute (NCI)

Not yet recruiting

A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia

Endometrial Hyperplasia | Grade 1 Endometrial Cancer

United States
Women's Hospital School Of Medicine Zhejiang University

Not yet recruiting

To Prevent Type I-II Myoma After TCRM Recurrence by Gonadotropin-releasing Hormone (GnRH )Analogues or Mifepristone (TCRM)

Submucous Leiomyoma of Uterus

China
Stephanie B. Seminara, MD

Recruiting

Kisspeptin Administration Subcutaneously to Patients With IHH

Hypogonadotropic Hypogonadism

United States
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Not yet recruiting

Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study

Premenopausal Breast Cancer | Hormone-receptor-positive Breast Cancer | Breast Cancer Patients at Intermediate to High Risk | Ovarian Function Suppression Combined With Aromatase Inhibitor or Tamoxifen or Torimefen

China
Bezmialem Vakif University

Recruiting

Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation Cycles

Infertility

Turkey
Zagazig University

Recruiting

Dydrogesterone-Primed Ovarian Stimulation Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in ICSI

Fertility Issues | Ovary Cyst

Egypt
Zhujiang Hospital

Recruiting

Efficacy and Safety of Apalutamide in Combination With 89Sr as Neoadjuvant Therapy in Prostate Cancer With ≤10 Bone Metastases

Prostate Cancer With ≤10 Bone Metastases

China

Search clinical trials for: Growth hormone releasing factor/Growth hormone releasing hormone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations